| Assessment of subclinical vascular disease associated with ankylosing spondylitis N Bodnár, G Kerekes, I Seres, G Paragh, J Kappelmayer, ZG Némethné, ... The Journal of Rheumatology 38 (4), 723-729, 2011 | 144 | 2011 |
| Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis K Gulyás, Á Horváth, E Végh, A Pusztai, Á Szentpétery, Z Pethö, A Váncsa, ... Clinical rheumatology 39, 167-175, 2020 | 76 | 2020 |
| Improvement in pain intensity, spine stiffness, and mobility during a controlled individualized physiotherapy program in ankylosing spondylitis ZN Gyurcsik, A András, N Bodnár, Z Szekanecz, S Szántó Rheumatology international 32, 3931-3936, 2012 | 62 | 2012 |
| Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept É Rákóczi, B Perge, E Végh, P Csomor, A Pusztai, S Szamosi, N Bodnár, ... Joint Bone Spine 83 (6), 675-679, 2016 | 56 | 2016 |
| Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B … A Váncsa, Z Szabó, S Szamosi, N Bodnár, E Végh, L Gergely, G Szűcs, ... The Journal of rheumatology 40 (5), 565-571, 2013 | 46 | 2013 |
| Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters Á Kemény-Beke, R Gesztelyi, N Bodnár, J Zsuga, G Kerekes, M Zsuga, ... Joint Bone Spine 78 (2), 184-187, 2011 | 44 | 2011 |
| Biologics—beyond the joints Z Szekanecz, S Szántó, Z Szabó, A Váncsa, S Szamosi, N Bodnár, ... Autoimmunity Reviews 9 (12), 820-824, 2010 | 42 | 2010 |
| Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis N Bodnár, Z Szekanecz, Z Prohászka, Á Kemény-Beke, ... Joint Bone Spine 79 (1), 63-66, 2012 | 37 | 2012 |
| Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis K Gulyas, N Bodnar, Z Nagy, S Szamosi, A Horvath, A Vancsa, E Vegh, ... The European Journal of Health Economics 15, 93-100, 2014 | 33 | 2014 |
| Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis A Hamar, Z Szekanecz, A Pusztai, M Czókolyová, E Végh, Z Pethő, ... Osteoporosis International, 1-9, 2021 | 31 | 2021 |
| Treatment of ankylosing spondylitis with biologics and targeted physical therapy: positive effect on chest pain, diminished chest mobility, and respiratory function. Z Gyurcsik, N Bodnár, Z Szekanecz, S Szántó Zeitschrift für Rheumatologie 72 (10), 2013 | 24 | 2013 |
| Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis S Póliska, T Besenyei, E Végh, A Hamar, A Pusztai, A Váncsa, N Bodnár, ... Arthritis Research & Therapy 21, 1-11, 2019 | 9 | 2019 |
| Soluble vascular biomarkers in rheumatoid arthritis and ankylosing spondylitis: Effects of 1-year antitumor necrosis factor-α therapy A Pusztai, A Hamar, Á Horváth, K Gulyás, E Végh, N Bodnár, G Kerekes, ... The Journal of Rheumatology 48 (6), 821-828, 2021 | 8 | 2021 |
| Angiotensin converting enzyme activity in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients B Soós, M Fagyas, Á Horváth, E Végh, A Pusztai, M Czókolyová, ... Frontiers in Medicine 8, 785744, 2022 | 7 | 2022 |
| Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients B Juhász, K Gulyás, Á Horváth, E Végh, A Pusztai, Á Szentpétery, Z Pethő, ... BMC Musculoskeletal Disorders 22, 1-9, 2021 | 6 | 2021 |
| Vascular rheumatology: atherosclerosis and cardiovascular disease in arthritis Z Szekanecz, E Végh, A Váncsa, S Szamosi, Z Szabó, N Bodnár, G Szücs, ... Reumatologia/Rheumatology 50 (4), 336-344, 2012 | 6 | 2012 |
| Effects of one-year tofacitinib therapy on lipids and adipokines in association with vascular pathophysiology in rheumatoid arthritis M Czókolyová, A Hamar, A Pusztai, G Tajti, E Végh, Z Pethő, N Bodnár, ... Biomolecules 12 (10), 1483, 2022 | 5 | 2022 |
| Associations of vascular and bone status in arthritis patients A Pusztai, A Hamar, M Czókolyová, K Gulyás, Á Horváth, E Végh, Z Pethő, ... Scientific Reports 11 (1), 19504, 2021 | 4 | 2021 |
| OP0272 Effects of Anti-TNF Therapy on Markers of Bone Homeostasis in Rheumatoid Arthritis and Ankylosing Spondylitis Ά Horváth, A Pusztai, K Gulyás, A Váncsa, E Végh, N Bodnár, P Csomor, ... Annals of the rheumatic diseases 74 (Suppl 2), 175-175, 2015 | 4 | 2015 |
| Akcelerált atherosclerosis és vasculopathiák autoimmun-reumatológiai betegségekben Z Szekanecz, P Soltész, G Kerekes, G Szűcs, S Szántó, O Tímár, H Dér, ... Immunol Szemle 2 (2), 4-14, 2010 | 4 | 2010 |
